Cargando…

T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients

Introduction: Restriction factors (RFs) suppress HIV-1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial. Methods: We profiled the expression of RFs in primary blood-derived mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolduan, Sebastian, Koppensteiner, Herwig, Businger, Ramona, Rebensburg, Stephanie, Kunze, Christine, Brack-Werner, Ruth, Draenert, Rika, Schindler, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964667/
https://www.ncbi.nlm.nih.gov/pubmed/28953327
http://dx.doi.org/10.7448/IAS.20.1.21865
_version_ 1783325222295830528
author Bolduan, Sebastian
Koppensteiner, Herwig
Businger, Ramona
Rebensburg, Stephanie
Kunze, Christine
Brack-Werner, Ruth
Draenert, Rika
Schindler, Michael
author_facet Bolduan, Sebastian
Koppensteiner, Herwig
Businger, Ramona
Rebensburg, Stephanie
Kunze, Christine
Brack-Werner, Ruth
Draenert, Rika
Schindler, Michael
author_sort Bolduan, Sebastian
collection PubMed
description Introduction: Restriction factors (RFs) suppress HIV-1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial. Methods: We profiled the expression of RFs in primary blood-derived mononuclear cells (PBMC) from therapy-naïve HIV-1 patients and quantified infection. Results: Overall, there was no correlation between individual RF expression and HIV-1 status in total PBMC. However, we identified a T cell population with low levels of intracellular CD2 and reduced expression of SAMHD1, p21 and SerinC5. CD2(low) T cells with reduced RF expression were markedly positive for HIV-1 p24. In contrast, CD2+ T cells were less infected and expressed higher levels of RFs. CD2(low) T cell infection correlated with viral loads and was associated with HIV-1 disease progression. Conclusions: In untreated therapy naïve chronic HIV-1 patients, RF expression in T cells is associated with CD2 expression and seems to influence viral loads. Our study suggests that RFs help to control HIV-1 infection in certain T cells in vivo and supports the potential for RFs as promising targets for therapeutic intervention.
format Online
Article
Text
id pubmed-5964667
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-59646672018-05-30 T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients Bolduan, Sebastian Koppensteiner, Herwig Businger, Ramona Rebensburg, Stephanie Kunze, Christine Brack-Werner, Ruth Draenert, Rika Schindler, Michael J Int AIDS Soc Research Article Introduction: Restriction factors (RFs) suppress HIV-1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial. Methods: We profiled the expression of RFs in primary blood-derived mononuclear cells (PBMC) from therapy-naïve HIV-1 patients and quantified infection. Results: Overall, there was no correlation between individual RF expression and HIV-1 status in total PBMC. However, we identified a T cell population with low levels of intracellular CD2 and reduced expression of SAMHD1, p21 and SerinC5. CD2(low) T cells with reduced RF expression were markedly positive for HIV-1 p24. In contrast, CD2+ T cells were less infected and expressed higher levels of RFs. CD2(low) T cell infection correlated with viral loads and was associated with HIV-1 disease progression. Conclusions: In untreated therapy naïve chronic HIV-1 patients, RF expression in T cells is associated with CD2 expression and seems to influence viral loads. Our study suggests that RFs help to control HIV-1 infection in certain T cells in vivo and supports the potential for RFs as promising targets for therapeutic intervention. Taylor & Francis 2017-09-19 /pmc/articles/PMC5964667/ /pubmed/28953327 http://dx.doi.org/10.7448/IAS.20.1.21865 Text en © Bolduan S et al; licensee International AIDS Society. http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported (CC BY 3.0) License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bolduan, Sebastian
Koppensteiner, Herwig
Businger, Ramona
Rebensburg, Stephanie
Kunze, Christine
Brack-Werner, Ruth
Draenert, Rika
Schindler, Michael
T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients
title T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients
title_full T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients
title_fullStr T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients
title_full_unstemmed T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients
title_short T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients
title_sort t cells with low cd2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic hiv-1 patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964667/
https://www.ncbi.nlm.nih.gov/pubmed/28953327
http://dx.doi.org/10.7448/IAS.20.1.21865
work_keys_str_mv AT bolduansebastian tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients
AT koppensteinerherwig tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients
AT busingerramona tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients
AT rebensburgstephanie tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients
AT kunzechristine tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients
AT brackwernerruth tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients
AT draenertrika tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients
AT schindlermichael tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients